Yukio Kobayashi Selected Research

Yukio Kobayashi Research Topics

Disease

23	Lymphoma (Lymphomas) 01/2019 - 01/2002
18	Neoplasms (Cancer) 06/2021 - 01/2002
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 08/2002
11	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2021 - 05/2007
11	B-Cell Lymphoma (Lymphoma, B Cell) 02/2021 - 01/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 02/2006
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2018 - 06/2009
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022 - 09/2010
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2022 - 06/2009
7	Leukemia 12/2020 - 08/2002
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 01/2009
6	Philadelphia Chromosome 01/2022 - 06/2009
6	Hematologic Neoplasms (Hematological Malignancy) 08/2017 - 08/2002
5	T-Cell Lymphoma (Lymphoma, T Cell) 10/2015 - 12/2002
4	Acute Promyelocytic Leukemia 12/2020 - 04/2013
4	Disease Progression 12/2020 - 08/2016
4	Thrombocytopenia (Thrombopenia) 10/2018 - 08/2010
4	Hodgkin Disease (Hodgkin's Disease) 05/2018 - 01/2013
4	Infections 08/2016 - 03/2002
4	Neutropenia 07/2015 - 08/2010
3	Febrile Neutropenia 11/2021 - 12/2010
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 06/2021 - 01/2009
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2019 - 11/2003
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2017 - 01/2013
3	Pneumonia (Pneumonitis) 04/2017 - 10/2010
3	Multiple Myeloma 10/2015 - 01/2008
3	Leukopenia 07/2015 - 08/2010
2	Residual Neoplasm 01/2022 - 01/2018
2	Anemia 11/2021 - 12/2010
2	Hemorrhage 12/2020 - 10/2004
2	Diarrhea 08/2017 - 10/2004
2	Fever (Fevers) 04/2017 - 11/2008
2	Abdominal Pain (Pain, Abdominal) 08/2016 - 05/2007
2	Lymphopenia (Lymphocytopenia) 07/2015 - 08/2010
2	Plasmacytoma 01/2015 - 02/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013 - 05/2004
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2010 - 05/2004
2	Anorexia 08/2010 - 01/2010
1	Leukocytosis (Pleocytosis) 12/2020
1	Bites and Stings (Sting) 04/2020
1	Paraproteinemias (Monoclonal Gammopathy) 07/2019
1	Tumor Lysis Syndrome 10/2018
1	Syncope (Fainting) 10/2018

Drug/Important Bio-Agent (IBA)

14	Rituximab (Mabthera)FDA Link 02/2021 - 11/2008
7	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 06/2009
6	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 11/2008
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 11/2008
6	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 11/2008
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2008
4	nilotinib FDA Link 01/2017 - 06/2009
3	Azacitidine (5 Azacytidine)FDA Link 11/2022 - 09/2011
3	Dasatinib (BMS 354825)FDA Link 01/2022 - 06/2011
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2020 - 11/2014
3	Pharmaceutical PreparationsIBA 10/2018 - 08/2010
3	AntibodiesIBA 05/2018 - 06/2009
3	Proteins (Proteins, Gene)FDA Link 02/2018 - 02/2005
3	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2004
3	Monoclonal AntibodiesIBA 10/2017 - 06/2009
3	Tyrosine Kinase InhibitorsIBA 09/2017 - 04/2012
3	SteroidsIBA 08/2016 - 03/2002
3	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 12/2010
2	EnzymesIBA 11/2022 - 10/2012
2	blinatumomabIBA 06/2022 - 04/2020
2	gilteritinibIBA 11/2021 - 10/2018
2	Cyclin D1IBA 06/2021 - 01/2002
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2020 - 10/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 08/2010
2	Immunoglobulin M (IgM)IBA 07/2019 - 01/2015
2	mogamulizumabIBA 01/2019 - 10/2017
2	tamibaroteneIBA 01/2019 - 11/2014
2	bosutinibIBA 09/2017 - 01/2015
2	Vasopressins (Vasopressin)IBA 08/2016 - 05/2007
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2015 - 01/2002
2	Epstein-Barr virus encoded RNA 1IBA 01/2015 - 01/2013
2	Gemtuzumab (Mylotarg)FDA Link 07/2011 - 05/2009
2	Etoposide (VP 16)FDA LinkGeneric 12/2010 - 11/2009
2	CalicheamicinsIBA 08/2010 - 05/2009
2	Bortezomib (Velcade)FDA Link 11/2008 - 01/2008
2	Cladribine FDA LinkGeneric 10/2004 - 07/2004
1	pevonedistatIBA 11/2022
1	ibrutinibIBA 06/2021
1	AnticoagulantsIBA 12/2020
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Amylases FDA Link 10/2018
1	fms-Like Tyrosine Kinase 3IBA 10/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2018
1	AnthracyclinesIBA 06/2018
1	LigandsIBA 05/2018

Therapy/Procedure

31	Therapeutics 06/2022 - 03/2002
19	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
5	Chemoradiotherapy 06/2018 - 02/2006
5	Transplantation 01/2018 - 07/2002
4	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2010
4	Stem Cell Transplantation 01/2019 - 05/2004
3	Radiotherapy 02/2021 - 02/2006
3	Combination Drug Therapy (Combination Chemotherapy) 04/2016 - 02/2006
2	Cell Transplantation 01/2018 - 04/2013
1	Oral Administration 06/2021
1	Remission Induction 12/2020